Questions with the most recent answer or edit.
Details up front: MKM · ecnoglutide. I would like to know whether this claim survives contact with evidence. If the answer is "nobody has tested that", I would like…
Conditions: survodutide · 40 °C · twenty-one days. The failure mode I am trying to avoid is making this decision emotionally. I have twelve months in view and I would…
Transit was eleven days with two scanning gaps, so the thermal history is partly inferred. I would like to define my thresholds before I have a result, for obvious…
What I am working with: dulaglutide · 3.33 mg/mL. This is a procedural question rather than a theoretical one, and I would like the procedure rather than the theory.…
Stated plainly: semaglutide · Changsha. The failure mode I am trying to avoid is making this decision emotionally. I have twelve months in view and I would like the…
I have three numbers on my report that all claim to measure roughly the same risk and they do not agree about how I am doing. LDL-C 2.6 mmol/L, which is described in…
This is the third vial from the same lot, so I can compare against two known-good ones. I have read the obvious sources and they disagree with each other, so I would…
The particulars: Qingdao · Finland. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am reasonably comfortable…
The particulars: 99.1% · semaglutide. I would rather understand the derivation than memorise the outcome. Two people I asked gave two answers that differ by a factor…
Details up front: mazdutide · 10 mg. This should be a straightforward calculation and I keep getting two different answers. The numbers are arbitrary; the method is…
I have the report as a PDF with the chromatogram on page two, so I can quote specifics. I can predict the outcome but I cannot explain it, which means I will get the…
Setup, so nobody has to ask: BCH · KP · New Zealand. I suspect the honest answer is that it depends, in which case I would like to know on what. Assume I can obtain…
The particulars: 1.7 mg · three weeks · reflux. I would like the mechanism, because I want to be able to reason about the cases nobody has written about. I have tried…
What I am working with: mazdutide · six weeks. This is a planning question. I know what my options are; I do not know how to weigh them. What I want is the minimum…
This is my second independent submission on material from the same supplier. I would rather over-plan the first cycle and simplify later. I am prepared to do the work…
Stated plainly: 95.2% · a C18 column · survodutide. I have read the primary source rather than the summary, which has left me with more questions. I understand the…
This is a question about interpretation, not about whether to act — I will take action questions elsewhere. I want to know whether this is a real physical effect or…
Setup, so nobody has to ask: Qingdao · South Africa. I want to understand what this actually establishes, as opposed to what it is being used to imply. My concern is…
The particulars: triglycerides · survodutide. I would like to define my thresholds before I have a result, for obvious reasons. I want a plan with explicit stopping…
What I have: a GLP-1 receptor agonist · sixteen weeks · 40 °C. I suspect the usual explanation for this is wrong, or at least incomplete. I am aware this may have a…
The specifics, since they change the answer: SURMOUNT-5 · headache · 5 mg. I have the document in front of me and I can read the numbers. What I cannot do is…
Stated plainly: 20 mg · 6.67 mg/mL. The units are where I keep going wrong, so please be explicit about them. I have sanity-checked the order of magnitude and it…
Details up front: Guangzhou · Sweden. I would like help reading this properly rather than being told what conclusion to reach. I have the full report including the…
I am reading the trial table rather than the press release, which is why the numbers differ. I can do the algebra. I am not confident about the conversion factors. If…